Alimam S, Villiers W, Dillon R, et al. Patients with triple-negative, JAK2V617F- and CALR-mutated essential thrombocythemia share a unique gene expression signature. Blood Adv. 2021;5(4):1059-1068.

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2021
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267109/
https://www.ncbi.nlm.nih.gov/pubmed/34137812
http://dx.doi.org/10.1182/bloodadvances.2021005271
_version_ 1783720071604994048
collection PubMed
description
format Online
Article
Text
id pubmed-8267109
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-82671092021-07-12 Alimam S, Villiers W, Dillon R, et al. Patients with triple-negative, JAK2V617F- and CALR-mutated essential thrombocythemia share a unique gene expression signature. Blood Adv. 2021;5(4):1059-1068. Blood Adv Erratum American Society of Hematology 2021-06-17 /pmc/articles/PMC8267109/ /pubmed/34137812 http://dx.doi.org/10.1182/bloodadvances.2021005271 Text en © 2021 by The American Society of Hematology
spellingShingle Erratum
Alimam S, Villiers W, Dillon R, et al. Patients with triple-negative, JAK2V617F- and CALR-mutated essential thrombocythemia share a unique gene expression signature. Blood Adv. 2021;5(4):1059-1068.
title Alimam S, Villiers W, Dillon R, et al. Patients with triple-negative, JAK2V617F- and CALR-mutated essential thrombocythemia share a unique gene expression signature. Blood Adv. 2021;5(4):1059-1068.
title_full Alimam S, Villiers W, Dillon R, et al. Patients with triple-negative, JAK2V617F- and CALR-mutated essential thrombocythemia share a unique gene expression signature. Blood Adv. 2021;5(4):1059-1068.
title_fullStr Alimam S, Villiers W, Dillon R, et al. Patients with triple-negative, JAK2V617F- and CALR-mutated essential thrombocythemia share a unique gene expression signature. Blood Adv. 2021;5(4):1059-1068.
title_full_unstemmed Alimam S, Villiers W, Dillon R, et al. Patients with triple-negative, JAK2V617F- and CALR-mutated essential thrombocythemia share a unique gene expression signature. Blood Adv. 2021;5(4):1059-1068.
title_short Alimam S, Villiers W, Dillon R, et al. Patients with triple-negative, JAK2V617F- and CALR-mutated essential thrombocythemia share a unique gene expression signature. Blood Adv. 2021;5(4):1059-1068.
title_sort alimam s, villiers w, dillon r, et al. patients with triple-negative, jak2v617f- and calr-mutated essential thrombocythemia share a unique gene expression signature. blood adv. 2021;5(4):1059-1068.
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267109/
https://www.ncbi.nlm.nih.gov/pubmed/34137812
http://dx.doi.org/10.1182/bloodadvances.2021005271

Ejemplares similares